'One Dose Of Psilocybin May Have Lasting Effects On Major Depression, Study Finds' - StatNews
Portfolio Pulse from Happy Mohamed
A recent study published in the Journal of the American Medical Association suggests that a single dose of psilocybin, a psychedelic compound produced by certain types of mushrooms, may have lasting benefits for people with major depressive disorder. The study adds to the growing body of evidence supporting the potential efficacy of psilocybin for depression treatment.
August 31, 2023 | 3:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The study's findings may positively impact CMPS, a company involved in the development of psilocybin-based therapies.
As a company involved in the development of psilocybin-based therapies, CMPS may benefit from the growing body of evidence supporting the efficacy of psilocybin for depression treatment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
The study's findings may positively impact CYBN, a company involved in the development of psilocybin-based therapies.
As a company involved in the development of psilocybin-based therapies, CYBN may benefit from the growing body of evidence supporting the efficacy of psilocybin for depression treatment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
The study's findings may positively impact DRUG, a company involved in the development of psilocybin-based therapies.
As a company involved in the development of psilocybin-based therapies, DRUG may benefit from the growing body of evidence supporting the efficacy of psilocybin for depression treatment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
The study's findings may positively impact ENVB, a company involved in the development of psilocybin-based therapies.
As a company involved in the development of psilocybin-based therapies, ENVB may benefit from the growing body of evidence supporting the efficacy of psilocybin for depression treatment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
The study's findings may positively impact MNMD, a company involved in the development of psilocybin-based therapies.
As a company involved in the development of psilocybin-based therapies, MNMD may benefit from the growing body of evidence supporting the efficacy of psilocybin for depression treatment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
The study's findings may positively impact SEEL, a company involved in the development of psilocybin-based therapies.
As a company involved in the development of psilocybin-based therapies, SEEL may benefit from the growing body of evidence supporting the efficacy of psilocybin for depression treatment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80